(140 days)
Not Found
No
The summary describes calibrators and controls for a turbidimetry assay, which is a standard laboratory technique and does not mention any AI/ML components.
No.
The device is used for in vitro diagnostic purposes to establish calibration curves and monitor the quantitative measurement of Lipoprotein (a), not for treating or diagnosing patients.
No
Explanation: The device is described as calibrators and controls for monitoring Lipoprotein (a) concentration, indicated for "in vitro diagnostic use" to establish calibration curves and monitor reagent performance. It is used with a diagnostic reagent system (Quantia Lp(a) reagents) but does not directly diagnose a condition itself.
No
The device description clearly states that the device consists of physical calibrators and controls (human serum) used with reagents and an ARCHITECT c System, which are hardware components. It is not solely software.
Yes, this device is an IVD (In Vitro Diagnostic).
Here's why:
- Explicit Statement: The "Intended Use / Indications for Use" section explicitly states: "For in vitro diagnostic use."
- Purpose: The device (Lp(a) Calibrators and Controls) is intended to be used with reagents to measure Lipoprotein (a) concentration in human serum or plasma. This is a diagnostic test performed outside of the body (in vitro).
- Context: The description clearly outlines its use in a laboratory setting ("on the ARCHITECT c Systems") for quantitative monitoring and calibration of a diagnostic test.
All of these points align with the definition of an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The Lp (a) Calibrators are for use in establishing the calibration curve for the Quantia Lp(a) reagents by turbidimetry on the ARCHITECT c Systems.
The Lo (a) Control I and Control II are intended for use as assayed quality control materials for the quantitative monitoring of Lipoprotein (a) with the Quantia Lp(a) reagents by turbidimetry on the ARCHITECT c Systems.
For in vitro diagnostic use.
Product codes (comma separated list FDA assigned to the subject device)
JIT, JJX
Device Description
The Lp (a) Calibrators are a set of 5 levels required to establish the calibration curve of the Quantia Lipoprotein (a) reagents (K050487) for the quantitative measurement of Lipoprotein (a) concentration in human serum or plasma using immunoturbidimetry technology on the ARCHITECT c Systems.
The Lp (a) Control are a set of 2 levels used to monitor the quantitative measurement of Lipoprotein (a) concentration in human serum or plasma with the Quantia Lipoprotein (a) reagents (K050487) using immunoturbidimetry technology on the ARCHITECT c Systems.
Quantia Lp(a) Reagent included two equivalent reagents presentation that only differ on the geographic distribution zone:
- Reference 7K00-40 Quantia Lp(a) Reagent (US) -
- Reference 7K00-01 Quantia Lp(a) Reagent (EX-US)
Both Quantia Lp(a) Reagents reference will use the Lp(a) Calibrators and Lp(a) Control products.
The human serum used in the Lp(a) Calibrators and Lp(a) Control is nonreactive for HBsAg, anti-HIV-1/HIV-2, and anti-HCV using FDA approved methods.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Value assigment: The value assignment for a new lot of Lp(a) Calibrators involves calibrating the Quantia Lp(a) on the ARCHITECT c8000 Clinical Chemistry System with the existing Master lot and running as samples, each level of the new manufactured calibrator lot, the Master lot and the previously released calibrator lot alternating the measurements until there are a total of 30 replicates for each material at each level.
The Control I and Control II mean values on the Lp(a) Control Value Sheet were calculated by data generated from multiple runs on the ARCHITECT c8000 System using the Quantia Lp(a) Reagent. The Control I and Control II target values should be within 10 to 30 mg/dL and 30 to 70 mg/dL respectively. Acceptance ranges are defined as ± 25% and ± 20% of Control I and Control II target values. The Control I and Control II lot specific target values and acceptable ranges are indicated on the Lp(a) Control Value Sheet included in the kit. It is recommended that each laboratory should establish its own Target values and Acceptance Range (mean and standard deviation).
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 862.1150 Calibrator.
(a)
Identification. A calibrator is a device intended for medical purposes for use in a test system to establish points of reference that are used in the determination of values in the measurement of substances in human specimens. (See also § 862.2 in this part.)(b)
Classification. Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.
0
510(k) Summary
This summary of the 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92.
The assigned 510(k) number is: K132400
Preparation Date: December 17, 2013
Applicant Name:
Mr. Joan Guixer Director of Quality Assurance and Requlatory Affairs Biokit S.A. Telephone number: (+34) 93 860 90 00 Fax number: (+34) 93 860 90 29 Llica d'Amunt Barcelona, Spain 08186
Device Name:
Calibrator: Classification Name: Calibrator, Secondary Trade Name: Lp(a) Calibrators Common Name: Calibrator Governing Regulation: 21 CFR 862.1150 Device Classification: Class II Classification Panel: Clinical Chemistry Product Code: JIT
Device Name:
Control: Classification Name: Quality Control Material (assayed and unassayed) Trade Name: Lp(a) Control Common Name: Single analyte Controls Governing Regulation: 21 CFR 862.1660 Device Classification: Class I, reserved Classification Panel: Clinical Chemistry Product Code: JJX
Legally marketed device to which equivalency is claimed:
The Lp(a) Calibrators and Lp(a) Control is substantially equivalent to other products in commercial distribution intended for similar use. We claim equivalence to the currently marketed Quantia Lp(a) Standard and Quantia Lp(a) Control cleared under K050487.
1
Intended Use of Device:
The Lp (a) Calibrators are for use in establishing the calibration curve for the Quantia Lp(a) reagents by turbidimetry on the ARCHITECT c Systems.
The Lo (a) Control I and Control II are intended for use as assayed quality control materials for the quantitative monitoring of Lipoprotein (a) with the Quantia Lp(a) reagents by turbidimetry on the ARCHITECT c Systems.
Description of Device:
The Lp (a) Calibrators are a set of 5 levels required to establish the calibration curve of the Quantia Lipoprotein (a) reagents (K050487) for the quantitative measurement of Lipoprotein (a) concentration in human serum or plasma using immunoturbidimetry technology on the ARCHITECT c Systems.
The Lp (a) Control are a set of 2 levels used to monitor the quantitative measurement of Lipoprotein (a) concentration in human serum or plasma with the Quantia Lipoprotein (a) reagents (K050487) using immunoturbidimetry technology on the ARCHITECT c Systems.
Quantia Lp(a) Reagent included two equivalent reagents presentation that only differ on the geographic distribution zone:
- Reference 7K00-40 Quantia Lp(a) Reagent (US) -
- Reference 7K00-01 Quantia Lp(a) Reagent (EX-US)
Both Quantia Lp(a) Reagents reference will use the Lp(a) Calibrators and Lp(a) Control products.
The human serum used in the Lp(a) Calibrators and Lp(a) Control is nonreactive for HBsAg, anti-HIV-1/HIV-2, and anti-HCV using FDA approved methods.
Stability
Unopened Lp(a) Calibrators and Lp(a) Control are stable for 32 months when stored at 2 to 8°C.
Real time shelf life is determined by comparing results of the calibrators and controls stored at 2 to 8°C with their assigned values. The Lp(a) Calibrators and Lp(a) Control were considered stable if the recovery values were within ±10% of the assigned values for controls and calibrators level 2 to 5 and ±3 mg/dL of assigned value for calibrator level 1.
Once reconstituted, the calibrators and controls are stable for 14 days when stored at 2 to 8°C.
The reconstituted Lp(a) Calibrators and Lp(a) Control were considered stable if the recovery values were within ±10% of the established mean at Day 0.
2
Value assigment
The value assignment for a new lot of Lp(a) Calibrators involves calibrating the Quantia Lp(a) on the ARCHITECT c8000 Clinical Chemistry System with the existing Master lot and running as samples, each level of the new manufactured calibrator lot, the Master lot and the previously released calibrator lot alternating the measurements until there are a total of 30 replicates for each material at each level.
The Control I and Control II mean values on the Lp(a) Control Value Sheet were calculated by data generated from multiple runs on the ARCHITECT c8000 System using the Quantia Lp(a) Reagent. The Control I and Control II target values should be within 10 to 30 mg/dL and 30 to 70 mg/dL respectively. Acceptance ranges are defined as ± 25% and ± 20% of Control I and Control II target values. The Control I and Control II lot specific target values and acceptable ranges are indicated on the Lp(a) Control Value Sheet included in the kit. It is recommended that each laboratory should establish its own Target values and Acceptance Range (mean and standard deviation).
Traceability
No reference material exists for Lp(a) in terms of mg/dL. In-house reference material was value-assigned using a commercial EIA (Enzyme Immunoassay) method.
Comparison of Technological Characteristics:
The Lp (a) Calibrators and Lp (a) Control are prepared from human sera containing Lp(a) with Kanamycin Monosulfate and Gentamicin Sulfate as preservatives. Both materials are indicated to be used in combination with the QUANTIA Lp(a) (K050487).
The currently marketed Quantia Lp(a) Standard and Quantia Lp(a) Control are prepared from human sera containing Lp(a) with sodium azide as preservative. Both materials are indicated to be used in combination with the QUANTIA Lp(a) (K050487).
Conclusion
The Lp(a) Calibrators and Lp(a) Control are substantially equivalent to predicate device (K050487).
3
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of an eagle with three legs.
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
December 19, 2013
BIOKIT S.A. JOAN GUIXER DIRECTOR OF QUALITY AND REGULATORY AFFAIRS CAN MALE, S/N LLICA d'AMUNT, BARCELONA 08186 SPAIN
Re: K132400
Trade/Device Name: Lp(a) Calibrators and Lp(a) Controls Regulation Number: 21 CFR 862.1150 Regulation Name: Calibrator Regulatory Class: II Product Code: JIT, JJX Dated: November 15, 2013 Received: November 18, 2013
Dear Mr. Guixer:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
4
Page 2-Mr. Guixer
If you desire specific advice for your device on our labeling regulations (21 CFR Parts 801 and 809), please contact the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours.
Carol C. Benson -S for
Courtney H. Lias, Ph.D. Director Division of Chemistry and Toxicology Devices Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
5
Indications for Use
510(k) Number (if known): K132400
Device Name: Lp(a) Calibrators and Lp(a) Controls
Indications for Use:
ייר ביינוני מועד
Lp (a) Calibrators
The Lp(a) Calibrators are for use in establishing the calibration curve for the Quantia Lp(a) reagents by turbidimetry on the ARCHITECT c Systems.
Lp (a) Controls
The Lp(a) Control I and Control II are intended for use as assayed quality control materials for the quantitative monitoring of Lipoprotein (a) with the Quantia Lp(a) reagents by turbidimetry on the ARCHITECT c Systems.
For in vitro diagnostic use.
Prescription Use _ X (21 CFR Part 801 Subpart D)
And/Or
Over the Counter Use _ (21 CFR Part 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE; CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
Ruth A. Chesler -S
Division Sign-Off Office of In Vitro Diagnostics and Radiological Health
K132400 510(k)
SIOK Indication for Use ARCHITECT Lp(a) Calibrators and Controls Page 1 of 1 December 2013